The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers

Andrew N Nicolaides, Andrew N Nicolaides

Abstract

Venous leg ulcers (VLUs) are the most severe manifestation of chronic venous disease (CVD). Due to their chronic nature, high recurrence rate and slow healing time, VLUs account for 80% of all leg ulcers seen in patients with CVD. VLUs impose a heavy burden on patients that reduces their quality of life; VLUs also represent a major socioeconomic impact due to the cost and duration of care. The primary medical approach to treating VLUs is local compression therapy in combination with venoactive drug (VAD) pharmacotherapy to promote the reduction of the inflammatory reaction initiated by venous hypertension. Micronized purified flavonoid fraction (MPFF; Daflon®) is the most widely prescribed VAD. MPFF counteracts the pathophysiologic mechanisms of CVD and ulceration and has proven to be an effective adjunct to compression therapy in patients with large and chronic VLUs. Two other non-VAD drugs, pentoxifylline and sulodexide, have also been shown to improve VLU healing and are also recommended in addition to compression therapy. However, MPFF is the only VAD with the highest strength of recommendations in the 2018 guidelines for the healing of VLUs.

Keywords: Chronic venous disease; Micronized purified flavonoid fraction; Venoactive drug therapy; Venoactive drugs; Venous leg ulcers.

References

    1. O’Donnell TF, Jr, Passman MA, Marston WA, Ennis WJ, Dalsing M, Kistner RL, et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery (R) and the American Venous Forum. J Vasc Surg. 2014;60(2 Suppl):3s–59s. doi: 10.1016/j.jvs.2014.04.049.
    1. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997;48(1):67–69. doi: 10.1177/000331979704800111.
    1. Lee AJ, Robertson LA, Boghossian SM, Allan PL, Ruckley CV, Fowkes FG, et al. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg Venous Lymphat Disord. 2015;3(1):18–26. doi: 10.1016/j.jvsv.2014.09.008.
    1. O’Donnell TF, Jr, Passman MA. Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) management of venous leg ulcers. Introduction. J Vasc Surg. 2014;60(2 Suppl):1S–2S. doi: 10.1016/j.jvs.2014.04.058.
    1. O’Donnell TF, Jr, Balk EM. The need for an intersociety consensus guideline for venous ulcer. J Vasc Surg. 2011;54(6):83S–90S. doi: 10.1016/j.jvs.2011.06.001.
    1. Dabiri G, Hammerman S, Carson P, Falanga V. Low-grade elastic compression regimen for venous leg ulcers–an effective compromise for patients requiring daily dressing changes. Int Wound J. 2015;12(6):655–661. doi: 10.1111/iwj.12186.
    1. Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018;19(6):1669. doi: 10.3390/ijms19061669.
    1. Robertson LA, Evans CJ, Lee AJ, Allan PL, Ruckley CV, Fowkes FG. Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study. Eur J Vasc Endovasc Surg. 2014;48(2):208–214. doi: 10.1016/j.ejvs.2014.05.017.
    1. Lozano Sanchez FS, Gonzalez-Porras JR, Diaz Sanchez S, Marinel Lo Roura J, Sanchez Nevarez I, Carrasco EC, et al. Negative impact of deep venous thrombosis on chronic venous disease. Thromb Res. 2013;131(4):e123–e126. doi: 10.1016/j.thromres.2013.01.011.
    1. Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maesenner M, Eklof B, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence part I. Int Angiol. 2018;37(3):181–254.
    1. Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med. 2018;378(22):2105–2114. doi: 10.1056/NEJMoa1801214.
    1. Nelson EA, Hillman A, Thomas K. Intermittent pneumatic compression for treating venous leg ulcers. The Cochrane database of systematic reviews. 2014(5):CD001899.
    1. Tobon J, Whitney JD, Jarrett M. Nutritional status and wound severity of overweight and obese patients with venous leg ulcers: a pilot study. J Vasc Nurs. 2008;26(2):43–52. doi: 10.1016/j.jvn.2007.12.002.
    1. Barber GA, Weller CD, Gibson SJ. Effects and associations of nutrition in patients with venous leg ulcers: a systematic review. J Adv Nurs. 2018;74(4):774–787. doi: 10.1111/jan.13474.
    1. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg. 2005;30(2):198–208. doi: 10.1016/j.ejvs.2005.04.017.
    1. Wu B, Lu J, Yang M, Xu T. Sulodexide for treating venous leg ulcers. The Cochrane database of systematic reviews. 2016(6):CD010694.
    1. Coccheri S, Bignamini AA. Pharmacological adjuncts for chronic venous ulcer healing. Phlebology. 2016;31(5):366–367. doi: 10.1177/0268355515619562.
    1. Nicolaides AN, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol. 2008;27(1):1–59. doi: 10.1177/000331970005100101.
    1. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(6 Suppl):454S–545S. doi: 10.1378/chest.08-0658.
    1. Nicolaides A, Kakkos S, Eklof B, Perrin M, Nelzen O, Neglen P, et al. Management of chronic venous disorders of the lower limbs guidelines according to scientific evidence. Int Angiol. 2014;33(2):87–208.
    1. Wittens C, Davies AH, Baekgaard N, Broholm R, Cavezzi A, Chastanet S, et al. Editor’s choice management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS) Eur J Vasc Endovasc Surg. 2015;49(6):678–737. doi: 10.1016/j.ejvs.2015.02.007.
    1. Gloviczki P, editor. Handbook of venous and lymphatic disorders: guidelines of the American Venous forum, fourth edition. 4. London: CRC Press; 2017.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever